- Home
- SGHT vs GHG Comparison
SGHT vs GHG Comparison
Compare SGHT & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- GHG
- Stock Information
- Founded
- SGHT 2011
- GHG 2004
- Country
- SGHT United States
- GHG China
- Employees
- SGHT N/A
- GHG N/A
- Industry
- SGHT Medical Specialities
- GHG Hotels/Resorts
- Sector
- SGHT Health Care
- GHG Consumer Discretionary
- Exchange
- SGHT Nasdaq
- GHG Nasdaq
- Market Cap
- SGHT 304.4M
- GHG 259.8M
- IPO Year
- SGHT 2021
- GHG 2018
- Fundamental
- Price
- SGHT $3.61
- GHG $2.51
- Analyst Decision
- SGHT Buy
- GHG
- Analyst Count
- SGHT 7
- GHG 0
- Target Price
- SGHT $6.27
- GHG N/A
- AVG Volume (30 Days)
- SGHT 206.9K
- GHG 12.9K
- Earning Date
- SGHT 11-07-2024
- GHG 02-25-2025
- Dividend Yield
- SGHT N/A
- GHG 3.97%
- EPS Growth
- SGHT N/A
- GHG N/A
- EPS
- SGHT N/A
- GHG 0.28
- Revenue
- SGHT $79,543,000.00
- GHG $201,166,731.00
- Revenue This Year
- SGHT $2.13
- GHG N/A
- Revenue Next Year
- SGHT $7.99
- GHG $8.78
- P/E Ratio
- SGHT N/A
- GHG $8.99
- Revenue Growth
- SGHT N/A
- GHG N/A
- 52 Week Low
- SGHT $3.30
- GHG $2.31
- 52 Week High
- SGHT $8.45
- GHG $3.89
- Technical
- Relative Strength Index (RSI)
- SGHT 41.47
- GHG 42.12
- Support Level
- SGHT $3.45
- GHG $2.40
- Resistance Level
- SGHT $3.64
- GHG $2.71
- Average True Range (ATR)
- SGHT 0.19
- GHG 0.10
- MACD
- SGHT 0.03
- GHG -0.00
- Stochastic Oscillator
- SGHT 38.04
- GHG 29.27
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.